Endeavor BioMedicines
PrivateLast Round
Series C
Apr 24, 2024
Total Funding Raised
$295.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Endeavor BioMedicines is a biotechnology company that develops precision medicines targeting the underlying genetic and cellular causes of life-threatening diseases such as pulmonary fibrosis and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endeavor BioMedicines Comparables
Compare Endeavor BioMedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 81% | |
| PureTech Health | 78% | |
| Contineum Therapeutics | 77% | |
Endeavor BioMedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 24, 2024 | ||||
| Series B | Feb 7, 2022 | ||||
| Series A | Jan 7, 2021 |
Key People
Founding team and executive leadership
Endeavor BioMedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C, Series B, Series A |
| Aberdeen Group plc | Series C |
| SymBiosis Capital Management | Series C |
| Omega Funds | Series C, Series B, Series A |
| Eckuity | Series C |
| Perceptive Advisors | Series C, Series B |
| abrdn Inc. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 68% MoM.
- May 1, 2025
Two posters accepted for American Thoracic Society 2025 International Conference.
Endeavor BioMedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endeavor BioMedicines's valuation, stock price, and market status.